Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype

Cell Adhesion and Migration

Volumn 10, Issue 4, 2016, Pages 360-367

  Hamilton, Gerhard ^a   Hochmair, Maximilian ^b   Rath, Barbara ^c   Klameth, Lukas ^c,d   Zeillinger, Robert ^e  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b OTTO WAGNER HOSPITAL   (Austria)

^c Ludwig Boltzmann Cluster of Translational Oncology   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

Author keywords

circulating tumor cells; dissemination; E cadherin; mesenchymal epithelial transition; small cell lung cancer; SOX2; stem cell markers

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; CHORIONIC GONADOTROPIN; FIBRONECTIN; GOOSECOID PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3BETA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 2; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX2; UVOMORULIN; VASCULOTROPIN RECEPTOR 2; CADHERIN; CDH1 PROTEIN, HUMAN; INSULIN; SOMATOMEDIN C; TUMOR MARKER;

ARTICLE; BONE METASTASIS; CANCER GROWTH; CANCER STAGING; CANCER STEM CELL; CELL PROLIFERATION; CIRCULATING TUMOR CELL; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; METASTASIS; PHENOTYPE; PLEURA EFFUSION; PROTEIN BINDING; PROTEIN EXPRESSION; SMALL CELL LUNG CANCER; WESTERN BLOTTING; CELL SHAPE; LUNG TUMOR; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; PLURIPOTENT STEM CELL; TUMOR CELL LINE; TUMOR EMBOLISM;

BETA CATENIN; BIOMARKERS, TUMOR; CADHERINS; CELL LINE, TUMOR; CELL SHAPE; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LUNG NEOPLASMS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PHENOTYPE; PLURIPOTENT STEM CELLS; SMALL CELL LUNG CARCINOMA; SPHEROIDS, CELLULAR;

EID: 84962336478     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.1080/19336918.2016.1155019     Document Type: Article

References (39)

1. E.A.Semenova, R.Nagel, A.Berns. Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev 2015; 29:1447-62; PMID:26220992; http://dx.doi.org/10.1101/gad.263145.115
2. G.P.Kalemkerian Advances in pharmacotherapy of small cell lung cancer. Expert Opin Pharmacother 2014; 15:2385-96. PMID:25255939; http://dx.doi.org/10.1517/14656566.2014.957180
3. M.Yu, A.Bardia, B.S.Wittner, S.L.Stott, M.E.Smas, D.T.Ting, S.J.Isakoff, J.C.Ciciliano, M.N.Wells, A.M.Shah, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013; 339:580-4; PMID:23372014; http://dx.doi.org/10.1126/science.1228522
4. G.Hamilton, O.Burghuber, R.Zeillinger. Circulating tumor cells in small cell lung cancer:ex vivo expansion. Lung 2015; 193:451-2; PMID:25821178; http://dx.doi.org/10.1007/s00408-015-9725-7
5. G.Hamilton, B.Rath, L.Klameth, M.Hochmair. Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer. Oncoscience 2015; 2:629-34; PMID:26328272.
6. J.H.Tsai, J.Yang. Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 2013; 27:2192-206; PMID:24142872; http://dx.doi.org/10.1101/gad.225334.113
7. A.Mitra, L.Mishra, S.Li. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget 2015; 6:10697-711; PMID:25986923.
8. J.P.Thiery Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2(6):442-54; PMID:12189386.
9. D.Yao, C.Dai, S.Peng. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res 2011; 9:1608-20; PMID:21840933; http://dx.doi.org/10.1158/1541-7786.MCR-10-0568
10. G.Barriere, P.Fici, G.Gallerani, F.Fabbri, W.Zoli, M.Rigaud. Circulating tumor cells and epithelial, mesenchymal and stemness markers:characterization of cell subpopulations. Ann Transl Med 2014; 2:109; PMID:25489583; http://dx.doi.org/10.3978/j.issn.2305-5839.2014.10.04
11. C.A.Schneider, W.S.Rasband, K.W.Eliceiri. NIH Image to ImageJ:25 years of image analysis. Nature Meth 2012; 9:671-5; PMID:22930834.
12. N.Yu, J.Zhou, F.Cui, X.Tang. Circulating tumor cells in lung cancer:detection methods and clinical applications. Lung 2015; 193:157-71; PMID:25690734; http://dx.doi.org/10.1007/s00408-015-9697-7
13. J.A.Galván, A.Astudillo, A.Vallina, G.Crespo, M.V.Folgueras, M.V.González. Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors. BMC Cancer 2014; 14:855; PMID:25413006; http://dx.doi.org/10.1186/1471-2407-14-855
14. M.G.Tokman, R.A.Porter, C.L.Williams. Regulation of cadherin-mediated adhesion by the small GTP-binding protein Rho in small cell lung carcinoma cells. Cancer Res 1997; 57:1785-93; PMID:9135023.
15. N.Karachaliou, R.Rosell, S.Viteri. The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung. Transl Lung Cancer Res 2013; 2:172-9; PMID:25806230; http://dx.doi.org/10.3978/j.issn.2218-6751.2013.01.01
16. S.Zhang, W.Cui. Sox2, a key factor in the regulation of pluripotency and neural differentiation. World J Stem Cells 2014; 6:305-11; PMID:25126380; http://dx.doi.org/10.4252/wjsc.v6.i3.305
17. K.Weina, J.Utikal. SOX2 and cancer:current research and its implications in the clinic. Clin Transl Med 2014; 3:19; PMID:25114775; http://dx.doi.org/10.1186/2001-1326-3-19
18. A.Vazquez-Martin, S.Cufí, E.López-Bonet, B.Corominas-Faja, E.Cuyàs, L.Vellon, J.M.Iglesias, O.Leis, A.G.Martín, J.A.Menendez. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells. Cell Cycle 2013; 12:3471-7; PMID:24107627; http://dx.doi.org/10.4161/cc.26692
19. T.Seymour, A.Nowak, F.Kakulas. Targeting Aggressive Cancer Stem Cells in Glioblastoma. Front Oncol 2015; 5:159; PMID:26258069; http://dx.doi.org/10.3389/fonc.2015.00159
20. S.B.Park, K.W.Seo, A.Y.So, M.S.Seo, K.R.Yu, S.K.Kang, K.S.Kang. SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC. Cell Death Differ 2012; 19:534-5; PMID:22015605; http://dx.doi.org/10.1038/cdd.2011.137
21. F.Yang, Y.Gao, J.Geng, D.Qu, Q.Han, J.Qi, G.Chen. Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer. Int J Clin Exp Pathol 2013; 6:2846-54; PMID:24294370.
22. Z.Zhang, C.Yang, W.Gao, T.1.Chen, T.Qian, J.Hu, Y.Tan FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer. Cancer Lett 2015; 361:240-50; PMID:25779673; http://dx.doi.org/10.1016/j.canlet.2015.03.008
23. V.Fendrich, M.Lauth. The role of pancreatic and duodenal homeobox 1 as a therapeutic target in pancreatic cancer. Expert Opin Ther Targets 2014; 18:1277-83. http://dx.doi.org/10.1517/14728222.2014.945427
24. F.Pedica, S.Beccari, S.Pedron, L.Montagna, P.Piccoli, C.Doglioni, M.Chilosi. PDX-1 (pancreatic/duodenal homeobox-1 protein 1). Pathologica 2014; 106:315-21; PMID:25845046.
25. I.Ischenko, O.Petrenko, M.J.Hayman. Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas. Proc Natl Acad Sci USA 2014; 111:3466-71; PMID:24550494; http://dx.doi.org/10.1073/pnas.1319911111
26. J.D.Johnson, E.Bernal-Mizrachi, E.U.Alejandro, Z.Han, T.B.Kalynyak, H.Li, J.L.Beith, J.Gross, G.L.Warnock, R.R.Townsend, et al. Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc Natl Acad Sci USA 2006; 103(51):19575-80; PMID:17158802.
27. K.L.Wu, M.Gannon, M.Peshavaria, M.F.Offield, E.Henderson, M.Ray, A.Marks, L.W.Gamer, C.V.Wright, R.Stein. Hepatocyte nuclear factor 3beta is involved in pancreatic beta-cell-specific transcription of the pdx-1 gene. Mol Cell Biol 1997; 17:6002-13; PMID:9315659.
28. B.A.Teicher Targets in small cell lung cancer. Biochem Pharmacol 2014; 87:211-9; PMID:24091017; http://dx.doi.org/10.1016/j.bcp.2013.09.014
29. R.N.Pillai, S.S.Ramalingam. Inhibition of insulin-like growth factor receptor:end of a targeted therapy? Transl Lung Cancer Res 2013; 2:14-22; PMID:25806201; http://dx.doi.org/10.3978/j.issn.2218-6751.2012.11.05
30. E.E.Vincent, D.J.Elder, J.Curwen, E.Kilgour, I.Hers, J.M.Tavaré. Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor. PLoS One 2013; 8:e66963; PMID:23826179; http://dx.doi.org/10.1371/journal.pone.0066963
31. V.P.Brahmkhatri, C.Prasanna, H.S.Atreya. Insulin-like growth factor system in cancer:novel targeted therapies. Biomed Res Int 2015; 2015:538019; PMID:25866791; http://dx.doi.org/10.1155/2015/538019
32. V.C.Russo, W.J.Azar, S.W.Yau, M.A.Sabin, G.A.Werther. IGFBP-2:The dark horse in metabolism and cancer. Cytokine Growth Factor Rev 2015; 26:329-346; PMID:25544066; http://dx.doi.org/10.1016/j.cytogfr.2014.12.001
33. M.A.Johnson, S.M.Firth. IGFBP-3:a cell fate pivot in cancer and disease. Growth Horm IGF Res2014; 24:164-173; PMID:24953254; http://dx.doi.org/10.1016/j.ghir.2014.04.007
34. H.Polioudaki, S.Agelaki, R.Chiotaki, E.Politaki, D.Mavroudis, A.Matikas, Georgoulias, P.A.Theodoropoulos. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer. BMC Cancer 2015; 15:399; PMID:25962645; http://dx.doi.org/10.1186/s12885-015-1386-7
35. A.Krohn, T.Ahrens, A.Yalcin, T.Plönes, J.Wehrle, S.Taromi, S.Wollner, M.Follo, T.Brabletz, S.A.Mani, R.Claus, B.Hackanson, M.Burger. Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC):phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes. PLoSOne 2014; 24;9:e100249; PMID:24959847; http://dx.doi.org/10.1371/journal.pone.0100249
36. Y.Chao, Q.Wu, C.Shepard, A.Wells. Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance. Clin Exp Metastasis 2012; 29:39-50; PMID:21964676; http://dx.doi.org/10.1007/s10585-011-9427-3
37. T.Tsuji, S.Ibaragi, K.Shima, M.G.Hu, M.Katsurano, A.Sasaki, G.F.Hu. Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth. Cancer Res 2008; 68:10377-86; PMID:19074907; http://dx.doi.org/10.1158/0008-5472.CAN-08-1444
38. L.B.Weiswald, D.Bellet, V.Dangles-Marie. Spherical cancer models in tumor biology. Neoplasia 2015; 17:1-15; PMID:25622895; http://dx.doi.org/10.1016/j.neo.2014.12.004
39. G.Hamilton, B.Rath, S.Holzer, M.Hochmair. Second-line therapy for small cell lung cancer:exploring the potential role of circulating tumor cell. Transl Lung Cancer Res 2016; 5:71-77; http://dx.doi.org/10.3978/j.issn.2218-6751.2015.12.12